The capital injection will facilitate the expansion of Aton’s infrastructure, which currently supports over 5,000 enrolled patients and screens tens of thousands more each month. By integrating research collection into standard practice, the firm seeks to bridge the gap between clinical care and medical data generation without disrupting physicians or their staff. Tom Sanders, CEO and Co-Founder of Aton Health, noted that the partnership validates the company's approach to making research more accessible and representative of broader patient populations. Cameron Perkins, a partner at Shore Search Partners, emphasized that the investment addresses a critical need to reduce operational burdens on providers while simultaneously increasing patient participation in innovative studies. Following this funding, Aton plans to prioritize technology development and team growth to support its broader market entry.